Chronic Subdural Hemorrhage (cSDH)
0
Pipeline Programs
3
Companies
2
Clinical Trials
1 recruiting
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
3 companies ranked by most advanced pipeline stage
Neurotech PharmaceuticalsRI - Cumberland
1 programNumen SILK coil embolization systemN/A1 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2025
2026
2027
2028
BALTBalt coils:
Neurotech PharmaceuticalsNumen SILK coil embolization system
Clinical Trials (2)
Total enrollment: 250 patients across 2 trials
Chronic Subdural Hematoma Embolization With Detachable Coils
Start: Jun 2026Est. completion: Sep 2028150 patients
N/ARecruiting
The CHALLENGER Registry
Start: Nov 2025Est. completion: Mar 2028100 patients
N/ASuspended
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
1 actively recruiting trials targeting 250 patients
3 companies competing in this space
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.